Profound Medical Corp.
PROF
Rank in Stocks
#15355
Profound Medical Corp., along with its subsidiaries, operates as a... Profound Medical Corp., along with its subsidiaries, operates as a commercial-stage medical technology firm. The company specializes in creating magnetic resonance (MR) guided ablation therapies designed to address prostate conditions, uterine fibroids, and to provide palliative pain management. Its market reach extends to Canada, Germany, the United States, and Finland. The company's primary offering is the TULSA-PRO system, which is engineered to integrate with magnetic resonance imaging (MRI) scanners within hospitals and clinical treatment facilities. Additionally, Profound Medical offers Sonalleve, a versatile therapeutic platform that treats uterine fibroids, delivers palliative pain relief for bone metastases, and provides non-invasive solutions for uterine fibroid treatment. Profound Medical Corp. maintains its corporate headquarters in Mississauga, Canada.
Share Price
$7.34
Last synced: 2026-11-09
Market Cap
$267.24M
Change (1 day)
1.80%
Change (1 year)
14.15%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Profound Medical Corp. (PROF)
Category
Healthcare
Operating Margin for Profound Medical Corp. (PROF)
Operating Margin as of November 2026 TTM: -184.35%
According to Profound Medical Corp.'s latest financial reports, its current operating margin (TTM) is -184.35%. At the end of 2025 the company had an operating margin of -256.27%.
Operating Margin history for Profound Medical Corp. from 2014 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -184.35% | -28.06% |
| 2025 | -256.27% | -17.22% |
| 2024 | -309.57% | -22.12% |
| 2023 | -397.50% | -10.29% |
| 2022 | -443.08% | 0.54% |
| 2021 | -440.72% | 70.65% |
| 2020 | -258.26% | -27.79% |
| 2019 | -357.63% | -53.92% |
| 2018 | -776.04% | 71.71% |
| 2017 | -451.94% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -100.08% |
US
|
|
| 18.08% | -100.10% |
IE
|
|
| 21.25% | -100.12% |
US
|
|
| 21.05% | -100.11% |
US
|
|
| 28.09% | -100.15% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Profound Medical Corp.'s operating margin
What is Profound Medical Corp.'s operating margin?
Profound Medical Corp.'s operating margin is -184.35%, as of Nov 2026.
What was Profound Medical Corp.'s operating margin in 2025?
In 2025, Profound Medical Corp.'s operating margin was -256.27%, compared with -309.57% in 2024.
How has Profound Medical Corp.'s operating margin changed since 2020?
From 2020 to 2025, Profound Medical Corp.'s operating margin was highest in 2025 (-256.27%) and lowest in 2022 (-443.08%).
How does Profound Medical Corp.'s operating margin compare with similar companies?
Profound Medical Corp.'s operating margin (-184.35%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.